Sanofi is a global life sciences company committed to improving access to healthcare and supporting the people we serve throughout the continuum of care. Sanofi iAwards initiative is a multi-institutional partnership program designed to support collaborations with academic investigators to accelerate innovative early stage, disease-relevant research towards the clinic. With this program, Sanofi aims to fund cutting-edge translational research that can contribute to our early-stage pipeline and ultimately benefit patients.
An Exclusive Opportunity for Vanderbilt University and Vanderbilt University Medical School (VUMC) Innovators: Vanderbilt University-VUMC are among a select group of institutions globally invited to engage in this opportunity.
For anyone interested in applying for Sanofi iAwards, please contact Swapneeta Date, Ph.D., Assistant Director of Life Sciences Collaborations.
Program Highlights:
-
Award winning proposals will receive $150,000 research funding including institutional direct and indirect costs for 12 months with up to 12 awards given in the 2023-2024 cycle
-
Potential opportunity to convert iAwards projects to sponsored research programs
-
Potential opportunity to subsequently create in-licensing and start-up opportunities within Sanofi’s early-stage portfolio
-
Awardees will have access to Sanofi R&D expertise and guidance